Cargando…

Epirubicin sequential natural killer cells enhanced the cytotoxicity to breast cancer cells in vitro

Detalles Bibliográficos
Autores principales:	Song, Yanqiu, Wang, Qian, Feng, Hui, Dong, Ying, Chen, Jingtao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645518/ http://dx.doi.org/10.1186/2051-1426-3-S2-P6

Ejemplares similares

Bortezomib sensitizes human glioblastoma stem cells to adoptive natural killer cell cytotoxicity
por: Grossenbacher, Steven, et al.
Publicado: (2015)

Enhanced natural killer cell targeting of cancer stem cells using Cetuximab
por: Grossenbacher, Steven K, et al.
Publicado: (2014)

Inhibition of natural killer (nk) cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome
por: Cifaldi, Loredana, et al.
Publicado: (2014)

Regulation of sepsis-induced IFNγ upon natural killer cell or natural killer T cell depletion in vivo
por: Christaki, E, et al.
Publicado: (2012)

Comparison of Cytotoxic activity and Interferon-g secretion by Natural Killer Cells in HIV-1 and HIV-2 infected individuals
por: Nuvor, Samuel Victor, et al.
Publicado: (2010)

KIR/HLA genotype combinations are determinants of Natural Killer (NK) cell mediated antibody-dependent cellular cytotoxicity (ADCC) potency
por: Parsons, MS, et al.
Publicado: (2012)

In vivo natural killer and natural killer T-cell depletion affects mortality in a murine pneumococcal pneumonia sepsis model
por: Christaki, E, et al.
Publicado: (2012)

Monocyte expression of MICA enhances the Natural Killer Cell response to antibody-coated tumor targets
por: Harper, Amanda, et al.
Publicado: (2014)

Natural Killer cells present in gut mucosa as potential ADCC effector cells
por: Sips, M, et al.
Publicado: (2012)

Natural killer cell status and tolerance in mouse and human bacterial sepsis
por: Souza-Fonseca-Guimaraes, F, et al.
Publicado: (2012)

Treatment of solid tumor with autologous natural killer cells in mouse models
por: Liao, Nan-Shih
Publicado: (2014)

Inhibiting autophagy increases epirubicin's cytotoxicity in breast cancer cells
por: Guo, Wei, et al.
Publicado: (2016)

Prognostically relevant natural killer cell-mediated immunoediting in acute myeloid leukemia
por: Chan, Christopher J, et al.
Publicado: (2013)

Natural Killer receptors distribution in Multiple Sclerosis
por: Martinez-Rodriguez, J E, et al.
Publicado: (2010)

Natural Killer (NK) cell responses at female genital mucosa to SIV vaginal challenge
por: Shang, L, et al.
Publicado: (2012)

Interleukin-21 activates natural killer cell activity against cetuximab-coated pancreatic tumor cells
por: McMichael, Elizabeth L, et al.
Publicado: (2015)

Tumor-derived alpha fetoprotein directly impacts human natural killer cell activity and viability
por: Vujanovic, Lazar, et al.
Publicado: (2015)

Transient regulatory T-cell (Treg) depletion with IL-2 diphtheria toxin fusion protein enhances clearance of acute myeloid leukemia by haploidentical natural killer (NK) cells
por: Bachanova, Veronika, et al.
Publicado: (2013)

Heterogeneity of cytotoxic T cell infiltration in breast and colorectal cancer
por: Ziai, James, et al.
Publicado: (2015)

Fucosylation enhances activity of cytotoxic T lymphocytes against breast cancer
por: Qiao, Na, et al.
Publicado: (2015)

Cross-talk between CD8+ T cells and natural killers: the role of mitochondrial Aa2+ transport
por: Uzhachenko, Roman, et al.
Publicado: (2014)

PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells
por: Guo, Yanan, et al.
Publicado: (2016)

Evaluation of aerosol IL-2 in sarcoma patients with lung metastases for future combination therapy with infused natural killer cells
por: Naing, Aung, et al.
Publicado: (2013)

Potent ex vivo expanded, human CD34+ cord blood-derived natural killer cells for cancer immunotherapy
por: Zhang, Xiaokui, et al.
Publicado: (2015)

Extensive natural killer cell receptor phenotyping on NK and T cells discloses differences in RA and PsA, potentially mirroring diverse immunoregulatory functions
por: van Bijnen, Sandra TA, et al.
Publicado: (2011)

P24. Aviscumine enhances NK- cytotoxicity against tumor cells
por: Gamerith, G, et al.
Publicado: (2014)

Preventing feedback activation of glycolytic ATP production enhances metformin cytotoxicity in breast cancer cells when oxidative phosphorylation is inhibited
por: Zhuang, Yongxian, et al.
Publicado: (2014)

Alpha fetoprotein directly induces a unique pro-inflammatory, IL-2 hyperresponsive phenotype in human natural killer cells
por: Vujanovic, Lazar, et al.
Publicado: (2014)

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy
por: Venizelos, Andreas, et al.
Publicado: (2022)

Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control
por: Lundqvist, Andreas, et al.
Publicado: (2015)

Imaging-based, non-radioactive measurements of natural killer cell activity provides comparable results as classic chromium release assays but with fewer cells and less labor
por: Sundararaman, Srividya, et al.
Publicado: (2014)

Mechanisms of apoptosis and cell-cycle arrest in subcutaneous breast tumours treated sequentially with doxorubicin followed by zoledronic acid
por: Ottewell, PD, et al.
Publicado: (2008)

P23. Efficient ex vivo lysis of acute myeloid leukaemic (AML) cells mediated by triplebodies with dual-targeting capability in conjunction with natural killer cells as effectors
por: Fey, G, et al.
Publicado: (2014)

Natural killer cells expanded on membrane-bound IL15 or IL21 activate different miRNA transcriptional profiles with functional consequences
por: Somanchi, Anitha, et al.
Publicado: (2015)

Enhanced Cytotoxicity of Natural Killer Cells following the Acquisition of Chimeric Antigen Receptors through Trogocytosis
por: Cho, Fu-Nan, et al.
Publicado: (2014)

Enhancement of in vitro antitumour activity of epirubicin in HER2+ breast cancer cells using immunoliposome formulation
por: Khaleseh, Farnaz, et al.
Publicado: (2021)

Dendritic cells cross-presenting tumor-derived antigens are eliminated by invariant natural killer T (iNKT) cells, impairing development of anti-tumor immunity to a mouse carcinoma
por: Pilones, Karsten A, et al.
Publicado: (2013)

Enhancement of Natural Killer Cell Cytotoxicity by Sodium/Iodide Symporter Gene-Mediated Radioiodine Pretreatment in Breast Cancer Cells
por: Kim, Hae Won, et al.
Publicado: (2013)

Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
por: Smith, Andressa A, et al.
Publicado: (2013)

Exploitation of gamma delta T cells in cancer immunotherapy as combined antigen-presenters and cancer cell killers
por: Holmen Olofsson, Gitte, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j3udcjogrhp8rhf4cnetgu8a8h